Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Classement en actions #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Prix de l'action
$1.62
Dernière synchronisation: 2026-08-25
Capitalisation boursière
$172.47M
Changement (1 jour)
-3.57%
Changement (1 an)
446.74%
Pays
US
Échange Cypherpunk Technologies Inc. (CYPH)

Catégorie

Historique des divisions d’actions pour Cypherpunk Technologies Inc. (CYPH)
L’action Cypherpunk Technologies Inc. (symbole : CYPH) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 26, 2026.
Une action CYPH achetée avant le Aug 26, 2026 équivaudrait aujourd’hui à 0 actions CYPH.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH